Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1998;83:305-313

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koyama, N.
Right arrow Articles by Clowes, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koyama, N.
Right arrow Articles by Clowes, A. W.
(Circulation Research. 1998;83:305-313.)
© 1998 American Heart Association, Inc.


Original Contribution

Heparan Sulfate Proteoglycans Mediate a Potent Inhibitory Signal for Migration of Vascular Smooth Muscle Cells

Noriyuki Koyama, Michael G. Kinsella, Thomas N. Wight, Ulf Hedin, , Alexander W. Clowes

From the Departments of Surgery (N.K., U.H., A.W.C.) and Pathology (M.G.K., T.N.W.), University of Washington, Seattle.

Correspondence to Alexander W. Clowes, MD, Department of Surgery, Box 356410, University of Washington, Seattle, WA 98195-6410. E-mail clowes{at}u.washington.edu

Abstract—Migration of vascular smooth muscle cells (SMCs) is a key step in vascular remodeling and formation of pathological lesions in diseased arteries and may be controlled by extracellular matrix (ECM) and by factors that regulate ECM composition, such as platelet-derived growth factor (PDGF). In culture, PDGF-AB and -BB enhance but PDGF-AA (although having no effect alone) suppresses SMC migration stimulated by other PDGF isoforms. To determine whether the migration-inhibitory mechanism of PDGF-AA was mediated by ECM composition, we examined baboon SMC migration in a Boyden chamber assay using filters coated with different ECM proteins. PDGF-AA suppressed the PDGF-BB–induced migration of baboon SMCs on a filter coated with basement membrane proteins (Matrigel) and fibronectin but failed to inhibit cell migration on a type I collagen (Vitrogen)-coated filter. Fibronectin and fibronectin fragments that contain heparin-binding domains permitted PDGF-AA inhibition of cell migration, but a fragment lacking heparin-binding domains did not. Treatment of SMCs with heparin lyases II and III, but not with chondroitin ABC lyase, diminished the PDGF-AA–mediated inhibition of migration. PDGF-AA stimulated accumulation of proteoglycan (PG) in the cell layer more potently than did PDGF-BB, whereas the turnover of cell layer PG was unaffected by either PDGF-AA or -BB. Northern blot analysis revealed that PDGF-AA increased syndecan-1 mRNA expression more than did PDGF-BB, whereas both PDGF isoforms decreased perlecan expression. The changes in cell migration and PG synthesis induced by PDGF-AA were accompanied by changes in the morphology of SMCs. PDGF-AA dramatically induced the spreading of SMCs, whereas the heparin lyase treatment of PDGF-AA–stimulated cultures diminished cell spreading. The data suggest that PDGF-AA selectively modifies heparan sulfate PG accumulation on SMCs and thereby influences the interactions of SMCs with heparin-binding ECM proteins. These interactions, in turn, generate signals that suppress SMC migration.


Key Words: heparan sulfate • smooth muscle cell • platelet-derived growth factor • extracellular matrix




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
J. M. Ricono, B. Wagner, Y. Gorin, M. Arar, A. Kazlauskas, G. G. Choudhury, and H. E. Abboud
PDGF receptor-{beta} modulates metanephric mesenchyme chemotaxis induced by PDGF AA
Am J Physiol Renal Physiol, February 1, 2009; 296(2): F406 - F417.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. C. Doran, N. Meller, and C. A. McNamara
Role of Smooth Muscle Cells in the Initiation and Early Progression of Atherosclerosis
Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 812 - 819.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. T. Gerthoffer
Mechanisms of Vascular Smooth Muscle Cell Migration
Circ. Res., March 16, 2007; 100(5): 607 - 621.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. Abramsson, S. Kurup, M. Busse, S. Yamada, P. Lindblom, E. Schallmeiner, D. Stenzel, D. Sauvaget, J. Ledin, M. Ringvall, et al.
Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development
Genes & Dev., February 1, 2007; 21(3): 316 - 331.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. Xiao, Y. Liu, and D. M. Templeton
Ca2+/calmodulin-dependent protein kinase II inhibition by heparin in mesangial cells
Am J Physiol Renal Physiol, January 1, 2005; 288(1): F142 - F149.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Segev, N. Nili, and B. H Strauss
The role of perlecan in arterial injury and angiogenesis
Cardiovasc Res, September 1, 2004; 63(4): 603 - 610.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Zhou, J. Wang, R. Cao, H. Morita, R. Soininen, K. M. Chan, B. Liu, Y. Cao, and K. Tryggvason
Impaired Angiogenesis, Delayed Wound Healing and Retarded Tumor Growth in Perlecan Heparan Sulfate-Deficient Mice
Cancer Res., July 15, 2004; 64(14): 4699 - 4702.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P.-K. Tran, K. Tran-Lundmark, R. Soininen, K. Tryggvason, J. Thyberg, and U. Hedin
Increased Intimal Hyperplasia and Smooth Muscle Cell Proliferation in Transgenic Mice With Heparan Sulfate-Deficient Perlecan
Circ. Res., March 5, 2004; 94(4): 550 - 558.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C.-m. Li, D. Newman, J. Khosla, and P. L. Sannes
Heparin Inhibits DNA Synthesis and Gene Expression in Alveolar Type II Cells
Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 345 - 352.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. M. Grzeszkiewicz, V. Lindner, N. Chen, S. C.-T. Lam, and L. F. Lau
The Angiogenic Factor Cysteine-Rich 61 (CYR61, CCN1) Supports Vascular Smooth Muscle Cell Adhesion and Stimulates Chemotaxis through Integrin {alpha}6{beta}1 and Cell Surface Heparan Sulfate Proteoglycans
Endocrinology, April 1, 2002; 143(4): 1441 - 1450.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Ishigami, D. K. Swertfeger, M. S. Hui, N. A. Granholm, and D. Y. Hui
Apolipoprotein E Inhibition of Vascular Smooth Muscle Cell Proliferation but Not the Inhibition of Migration Is Mediated Through Activation of Inducible Nitric Oxide Synthase
Arterioscler Thromb Vasc Biol, April 1, 2000; 20(4): 1020 - 1026.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Paka, I. J. Goldberg, J. C. Obunike, S. Y. Choi, U. Saxena, I. D. Goldberg, and S. Pillarisetti
Perlecan Mediates the Antiproliferative Effect of Apolipoprotein E on Smooth Muscle Cells. AN UNDERLYING MECHANISM FOR THE MODULATION OF SMOOTH MUSCLE CELL GROWTH?
J. Biol. Chem., December 17, 1999; 274(51): 36403 - 36408.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Christen, M.-L. Bochaton-Piallat, P. Neuville, S. Rensen, M. Redard, G. van Eys, and G. Gabbiani
Cultured Porcine Coronary Artery Smooth Muscle Cells : A New Model With Advanced Differentiation
Circ. Res., July 9, 1999; 85(1): 99 - 107.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. K. Swertfeger and D. Y. Hui
Apolipoprotein E Receptor Binding Versus Heparan Sulfate Proteoglycan Binding in Its Regulation of Smooth Muscle Cell Migration and Proliferation
J. Biol. Chem., June 29, 2001; 276(27): 25043 - 25048.
[Abstract] [Full Text] [PDF]